Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus bupivacaine + dexmedetomidine TAP block for postoperative pain after inguinal hernia surgery
IRCT20121216011766N5Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine and dexmedetomidine in postoperative pain (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Pain control. Started Mar 2019; status: completed.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20121216011766N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121216011766N5.